Defensins And LL-37: A Review Of Function In The Gingival Epithelium

Periodontology 2000

Volumn 63, Issue 1, 2013, Pages 67-79

  Greer, Ara ^a   Zenobia, Camille ^a   Darveau, Richard P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; ANTIMICROBIAL CATIONIC PEPTIDE; BETA DEFENSIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; DEFENSIN;

ADAPTIVE IMMUNITY; ANATOMY AND HISTOLOGY; BACTERIA; CHEMOTAXIS; EPITHELIUM; GINGIVA; HOMEOSTASIS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; PERIODONTIUM;

ADAPTIVE IMMUNITY; ALPHA-DEFENSINS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BETA-DEFENSINS; CHEMOTAXIS; DEFENSINS; EPITHELIAL ATTACHMENT; EPITHELIUM; GINGIVA; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE;

EID: 84881509396     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/prd.12028     Document Type: Article

References (79)

1. Abiko Y, Saitoh M, Nishimura M, Yamazaki M, Sawamura D, Kaku T. Role of beta-defensins in oral epithelial health and disease. Med Mol Morphol 2007: 40: 179-184.
2. Al-Qutub MN, Braham PH, Karimi-Naser LM, Liu X, Genco CA, Darveau RP. Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis lipopolysaccharide. Infect Immun 2006: 74: 4474-4485.
3. Attström R, Schroeder HE. Effect of experimental neutropenia on initial gingivitis in dogs. Scand J Dent Res 1979: 87: 7-23.
4. Befus AD, Mowat C, Gilchrist M, Hu J, Solomon S, Bateman A. Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J Immunol 1999: 163: 947-953.
5. Bosshardt DD, Lang NP. The junctional epithelium: from health to disease. J Dent Res 2005: 84: 9-20.
6. Brancatisano FL, Maisetta G, Barsotti F, Esin S, Miceli M, Gabriele M, Giuca MR, Campa M, Batoni G. Reduced human beta defensin 3 in individuals with periodontal disease. J Dent Res 2011: 90: 241-245.
7. Bucki R, Leszczynska K, Namiot A, Sokolowski W. Cathelicidin LL-37: a multitask antimicrobial peptide. Arch Immunol Ther Exp (Warsz) 2010: 58: 15-25.
8. Bullard RS, Gibson W, Bose SK, Belgrave JK, Eaddy AC, Wright CJ, Hazen-Martin DJ, Lage JM, Keane TE, Ganz TA, Donald CD. Functional analysis of the host defense peptide Human Beta Defensin-1: new insight into its potential role in cancer. Mol Immunol 2008: 45: 839-848.
9. Campbell EL, Serhan CN, Colgan SP. Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators. J Immunol 2011: 187: 3475-3481.
10. Carrassi A, Abati S, Santarelli G, Vogel G. Periodontitis in a patient with chronic neutropenia. J Periodontol 1989: 60: 352-357.
11. Chaly YV, Paleolog EM, Kolesnikova TS, Tikhonov II, Petratchenko EV, Voitenok NN. Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells. Eur Cytokine Netw 2000: 11: 257-266.
12. Champagne CM, Buchanan W, Reddy MS, Preisser JS, Beck JD, Offenbacher S. Potential for gingival crevice fluid measures as predictors of risk for periodontal diseases. Periodontol 2000 2003: 31: 167-180.
13. Coats SR, Jones JW, Do CT, Braham PH, Bainbridge BW, To TT, Goodlett DR, Ernst RK, Darveau RP. Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4'-phosphatase activities. Cell Microbiol 2009: 11: 1587-1599.
14. Curtis MA, Percival RS, Devine D, Darveau RP, Coats SR, Rangarajan M, Tarelli E, Marsh PD. Temperature-dependent modulation of Porphyromonas gingivalis lipid A structure and interaction with the innate host defenses. Infect Immun 2011: 79: 1187-1193.
15. da Silva BR, de Freitas VA, Nascimento-Neto LG, Carneiro VA, Arruda FV, de Aguiar AS, Cavada BS, Teixeira EH. Antimicrobial peptide control of pathogenic microorganisms of the oral cavity: a review of the literature. Peptides 2012: 36: 315-321.
16. Dale BA, Fredericks LP. Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol 2005: 7: 119-133.
17. Dale BA, Krisanaprakornkit S. Defensin antimicrobial peptides in the oral cavity. J Oral Pathol Med 2001: 30: 321-327.
18. Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol 2010: 8: 481-490.
19. Darveau RP, Tanner A, Page RC. The microbial challenge in periodontitis. Periodontol 2000 1997: 14: 12-32.
20. Diamond G, Ryan L. Beta-defensins: what are they really doing in the oral cavity? Oral Dis 2011: 17: 628-635.
21. Diamond G, Beckloff N, Ryan LK. Host defense peptides in the oral cavity and the lung: similarities and differences. J Dent Res 2008: 87: 915-927.
22. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996: 87: 2095-2147.
23. Dixon DR, Bainbridge BW, Darveau RP. Modulation of the innate immune response within the periodontium. Periodontol 2000 2004: 35: 53-74.
24. Eskan MA, Benakanakere MR, Rose BG, Zhang P, Zhao J, Stathopoulou P, Fujioka D, Kinane DF. Interleukin-1beta modulates proinflammatory cytokine production in human epithelial cells. Infect Immun 2008: 76: 2080-2089.
25. Ganz T, Lehrer RI. Defensins. Curr Opin Immunol 1994: 6: 584-589.
26. Garcia JR, Krause A, Schulz S, Rodriguez-Jimenez FJ, Kluver E, Adermann K, Forssmann U, Frimpong-Boateng A, Bals R, Forssmann WG. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 2001: 15: 1819-1821.
27. Gemmell E, Walsh LJ, Savage NW, Seymour GJ. Adhesion molecule expression in chronic inflammatory periodontal disease tissue. J Periodontal Res 1994: 29: 46-53.
28. Giannobile WV. Crevicular fluid biomarkers of oral bone loss. Curr Opin Periodontol 1997: 4: 11-20.
29. Gomes Pde S, Fernandes MH. Defensins in the oral cavity: distribution and biological role. J Oral Pathol Med 2010: 39: 1-9.
30. Gorr SU, Abdolhosseini M. Antimicrobial peptides and periodontal disease. J Clin Periodontol 2011: 38(Suppl 11): 126-141.
31. Gupta S, Ghosh SK, Scott ME, Bainbridge B, Jiang B, Lamont RJ, McCormick TS, Weinberg A. Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation. J Biol Chem 2010: 285: 36523-36531.
32. Gursoy UK, Kononen E. Understanding the roles of gingival beta-defensins. J Oral Microbiol 2012: 4: doi: 10.3402/jom.v4i0.15127.
33. Hakkinen L, Uitto VJ, Larjava H. Cell biology of gingival wound healing. Periodontol 2000 2000: 24: 127-152.
34. Hart TC, Shapira L, Van Dyke TE. Neutrophil defects as risk factors for periodontal diseases. J Periodontol 1994: 65: 521-529.
35. Hensel JA, Chanda D, Kumar S, Sawant A, Grizzle WE, Siegal GP, Ponnazhagan S. LL-37 as a therapeutic target for late stage prostate cancer. Prostate 2011: 71: 659-670.
36. Jin L. An update on innate defense molecules of human gingiva. Periodontol 2000 2011: 56: 125-142.
37. Joly S, Maze C, McCray PB Jr, Guthmiller JM. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 2004: 42: 1024-1029.
38. Kamma J, Mombelli A, Tsinidou K, Vasdekis V, Giannopoulou C. Cytokines in gingival crevicular fluid of adolescents and young adults. Oral Microbiol Immunol 2009: 24: 7-10.
39. Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, Issbrücker K, Unterberger P, Zaiou M, Lebherz C, Karl A, Raake P, Pfosser A, Boekstegers P, Welsch U, Hiemstra PS, Vogelmeier C, Gallo RL, Clauss M, Bals R. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003: 111: 1665-1672.
40. Kohlgraf KG, Pingel LC, Dietrich DE, Brogden KA. Defensins as anti-inflammatory compounds and mucosal adjuvants. Future Microbiol 2010: 5: 99-113.
41. Kohlgraf KG, Ackermann A, Lu X, Burnell K, Belanger M, Cavanaugh JE, Xie H, Progulske-Fox A, Brogden KA. Defensins attenuate cytokine responses yet enhance antibody responses to Porphyromonas gingivalis adhesins in mice. Future Microbiol 2010: 5: 115-125.
42. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 1997: 14: 33-53.
43. Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW, Dale BA. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun 2000: 68: 2907-2915.
44. Kucukkolbasi H, Kucukkolbasi S, Dursun R, Ayyildiz F, Kara H. Determination of defensin HNP-1 in human saliva of patients with oral mucosal diseases. J Immunoassay Immunochem 2011: 32: 284-295.
45. Lehrer RI, Lu W. Alpha-Defensins in human innate immunity. Immunol Rev 2012: 245: 84-112.
46. Lehrer RI, Barton A, Daher KA, Harwig SS, Ganz T, Selsted ME. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest 1989: 84: 553-561.
47. Madhwani T, McBain AJ. Compositional modification of nascent in vitro dental plaques by human host-defence peptides. FEMS Immunol Med Microbiol 2012: 64: 374-381.
48. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996: 381: 77-80.
49. McCormick TS, Weinberg A. Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity. Periodontol 2000 2010: 54: 195-206.
50. Mookherjee N, Brown KL, Bowdish DM, Doria S, Falsafi R, Hokamp K, Roche FM, Mu R, Doho GH, Pistolic J, Powers JP, Bryan J, Brinkman FS, Hancock RE. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 2006: 176: 2455-2464.
51. Moughal NA, Adonogianaki E, Thornhill MH, Kinane DF. Endothelial cell leukocyte adhesion molecule-1 (ELAM-1) and intercellular adhesion molecule-1 (ICAM-1) expression in gingival tissue during health and experimentally-induced gingivitis. J Periodontal Res 1992: 27: 623-630.
52. Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, Tanaka S, Heumann D. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin Diagn Lab Immunol 2002: 9: 972-982.
53. Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K, Nagaoka I, Okumura K, Ogawa H. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 2007: 127: 594-604.
54. Nylander K, Danielsen B, Fejerskov O, Dabelsteen E. Expression of the endothelial leukocyte adhesion molecule-1 (ELAM-1) on endothelial cells in experimental gingivitis in humans. J Periodontol 1993: 64: 355-357.
55. Otte JM, Werner I, Brand S, Chromik AM, Schmitz F, Kleine M, Schmidt WE. Human beta defensin 2 promotes intestinal wound healing in vitro. J Cell Biochem 2008: 104: 2286-2297.
56. Otto M. Bacterial sensing of antimicrobial peptides. Contrib Microbiol 2009: 16: 136-149.
57. Page RC, Beatty P, Waldrop TC. Molecular basis for the functional abnormality in neutrophils from patients with generalized prepubertal periodontitis. J Periodontal Res 1987: 22: 182-183.
58. Pingel LC, Kohlgraf KG, Hansen CJ, Eastman CG, Dietrich DE, Burnell KK, Srikantha RN, Xiao X, Bélanger M, Progulske-Fox A, Cavanaugh JE, Guthmiller JM, Johnson GK, Joly S, Kurago ZB, Dawson DV, Brogden KA. Human beta-defensin 3 binds to hemagglutinin B (rHagB), a non-fimbrial adhesin from Porphyromonas gingivalis, and attenuates a pro-inflammatory cytokine response. Immunol Cell Biol 2008: 86: 643-649.
59. Presicce P, Giannelli S, Taddeo A, Villa ML, Della Bella S. Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91. J Leukoc Biol 2009: 86: 941-948.
60. Roberts FA, Darveau RP. Beneficial bacteria of the periodontium. Periodontol 2000 2002: 30: 40-50.
61. Rosenfeld Y, Papo N, Shai Y. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J Biol Chem 2006: 281: 1636-1643.
62. Schiott CR, Loe H. The origin and variation in number of leukocytes in the human saliva. J Periodontal Res 1970: 5: 36-41.
63. Schramm R, Thorlacius H. Neutrophil recruitment in mast cell-dependent inflammation: inhibitory mechanisms of glucocorticoids. Inflamm Res 2004: 53: 644-652.
64. Scott MG, Davidson DJ, Gold MR, Bowdish D, Hancock RE. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol 2002: 169: 3883-3891.
65. Suphasiriroj W, Mikami M, Shimomura H, Sato S. Specificity of antimicrobial peptide LL-37 to neutralize periodontopathogenic lipopolysaccharide activity in human oral fibroblasts. J Periodontol 2013: 84: 256-264.
66. Tonetti MS. Molecular factors associated with compartmentalization of gingival immune responses and transepithelial neutrophil migration. J Periodontal Res 1997: 32: 104-109.
67. Tonetti MS, Imboden MA, Lang NP. Neutrophil migration into the gingival sulcus is associated with transepithelial gradients of interleukin-8 and ICAM-1. J Periodontol 1998: 69: 1139-1147.
68. Tonetti MS, Imboden MA, Gerber L, Lang NP, Laisue J, Mueller C. Localized expression of mRNA for phagocyte-specific hemotactic cytokines in human periodontal infections. Infect Immun 1994: 62: 4005-4014.
69. Tsukamoto Y, Usui M, Yamamoto G, Takagi Y, Tachikawa T, Yamamoto M, Nakamura M. Role of the junctional epithelium in periodontal innate defense and homeostasis. J Periodontal Res 2012: 47: 750-757.
70. Turkoglu O, Kandiloglu G, Berdeli A, Emingil G, Atilla G. Antimicrobial peptide hCAP-18/LL-37 protein and mRNA expressions in different periodontal diseases. Oral Dis 2011: 17: 60-67.
71. Valore EV, Ganz T. Posttranslational processing of defensins in immature human myeloid cells. Blood 1992: 79: 1538-1544.
72. Van Dyke TE. The management of inflammation in periodontal disease. J Periodontol 2008: 79: 1601-1608.
73. Waldrop TC, Anderson DC, Hallmon WW, Schmalstieg FC, Jacobs RL. Periodontal manifestations of the heritable Mac-1, LFA-1, deficiency syndrome. Clinical, histopathologic and molecular characteristics. J Periodontol 1987: 58: 400-416.
74. Walters SM, Dubey VS, Jeffrey NR, Dixon DR. Antibiotic-induced Porphyromonas gingivalis LPS release and inhibition of LPS-stimulated cytokines by antimicrobial peptides. Peptides 2010: 31: 1649-1653.
75. Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 2004: 22: 181-215.
76. Yang J, Hooper WC, Phillips DJ, Talkington DF. Interleukin-1beta responses to Mycoplasma pneumoniae infection are cell-type specific. Microb Pathog 2003: 34: 17-25.
77. Yeung AT, Gellatly SL, Hancock RE. Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci 2011: 68: 2161-2176.
78. Yin L, Chino T, Horst OV, Hacker BM, Clark EA, Dale BA, Chung WO. Differential and coordinated expression of defensins and cytokines by gingival epithelial cells and dendritic cells in response to oral bacteria. BMC Immunol 2010: 11: 37.
79. Zhang H, Porro G, Orzech N, Mullen B, Liu M, Slutsky AS. Neutrophil defensins mediate acute inflammatory response and lung dysfunction in dose-related fashion. Am J Physiol Lung Cell Mol Physiol 2001: 280: L947-L954.